Pramana Inc. and Gestalt Diagnostics Inc. have announced a strategic partnership that will change the pathology industry. Together, they will offer an AI-powered, end-to-end digital pathology platform. Academic medical centres, health systems, and labs will all have access to the platform. Pramana’s SpectralHT scanning software and Gestalt’s PathFlow software can quickly, precisely, and automatically scan slides by combining AI algorithms and image analysis. With Gestalt’s Image Management System, the cutting-edge technology can be applied post-scan or during the processing phase. Management of Pramana’s DICOM images takes place directly on the platform employed by Gestalt.
Also Read: Missed Warnings: Examining the Oversight Failures Leading to the Collapse of SVB
The partnership makes each company’s technology better by making it easier for the Pramana scanners and PathFlow, Gestalt’s award-winning digital pathology solution, to talk to each other. According to Lisa-Jean Clifford, Gestalt COO & Chief Strategy Officer, the collaboration embodies the business’s philosophy of providing pathologists, scientists, and academics with new diagnostic and research support methods. This collaboration between two innovative technology firms has the potential to significantly impact how doctors and pathologists diagnose and treat patients, train residents, and lay the groundwork for new scientific discoveries. Moreover, the partnership between Pramana and Gestalt Diagnostics will advance the global healthcare industry. As highlighted by Prasanth Perugupalli, Chief Product Officer at Pramana, digital pathology has crossed the technology adoption chasm and is actively being pursued outside of researchers.
Also Read: Shake Shack: The Burger Brand That Expanded Through Word Of Mouth
Digital Pathology 2.0, the new benchmark for whole slide imaging, is being pioneered by Pramana. With the goal of empowering pathologists, automating lab procedures, and facilitating algorithm developers. The partnership with Gestalt will give labs and pathologists the full slide imaging quality. They’ve come to expect and boost their confidence in adopting digital technology. By enhancing the precision and effectiveness of pathology diagnosis and research support. The AI-powered, end-to-end digital pathology platform will ultimately improve patient outcomes.
This AI-powered digital pathology platform will enable labs and pathologists to work more productively. By automating lab processes, reducing human error, and allowing pathologists to make more precise diagnoses. As a result, this technology will have a significant impact on the field of pathology. Additionally, it will lay the groundwork for scientists to develop fresh approaches that will improve healthcare everywhere. By streamlining the interaction between Pramana’s SpectralHT scanning solution and Gestalt’s PathFlow solution, this partnership will improve each company’s technological offering. Ultimately, this collaboration will bring new methods of diagnostic and research support. Directly to pathologists, scientists, and academics, thereby advancing the healthcare industry globally.
The strategic alliance between Pramana Inc. and Gestalt Diagnostics Inc. will transform the pathology sector. By delivering an AI-powered, end-to-end digital pathology platform. That will raise the precision and effectiveness of pathology diagnosis and research support. This collaboration will have a big impact on the equipment used to diagnose and treat patients. Train residents and pathologists, and give scientists a base on which to build novel remedies that will improve healthcare all over the world.
